DEVENDA Trademark

Trademark Overview


On Tuesday, June 30, 2015, a trademark application was filed for DEVENDA with the United States Patent and Trademark Office. The USPTO has given the DEVENDA trademark a serial number of 86678823. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 30, 2018. This trademark is owned by Novartis AG. The DEVENDA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the preve...
devenda

General Information


Serial Number86678823
Word MarkDEVENDA
Filing DateTuesday, June 30, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 30, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2015

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, July 30, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 30, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 28, 2017EXTENSION 4 GRANTED
Thursday, December 28, 2017EXTENSION 4 FILED
Thursday, December 28, 2017TEAS EXTENSION RECEIVED
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2017EXTENSION 3 GRANTED
Friday, June 16, 2017EXTENSION 3 FILED
Friday, June 16, 2017TEAS EXTENSION RECEIVED
Thursday, December 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 27, 2016EXTENSION 2 GRANTED
Tuesday, December 27, 2016EXTENSION 2 FILED
Tuesday, December 27, 2016TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 24, 2016EXTENSION 1 GRANTED
Friday, June 24, 2016EXTENSION 1 FILED
Friday, June 24, 2016TEAS EXTENSION RECEIVED
Tuesday, December 29, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 3, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 25, 2015ASSIGNED TO EXAMINER
Tuesday, July 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 3, 2015NEW APPLICATION ENTERED IN TRAM